DUBLIN, July 14, 2022 /PRNewswire/ — The “Optical Coherence Tomography (OCT) for Ophthalmology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for Optical Coherence Tomography (OCT) for Ophthalmology was estimated at US$526.2 Million in the year 2020, and is projected to reach a revised size of US$754.4 Million by 2026, growing at a CAGR of 6.3% over the analysis period. Conventional OCT Systems, one of the segments analyzed in the report, is projected to grow at a 5.8% CAGR to reach US$667.4 Million by the end of the analysis period.
Global Optical Coherence Tomography (OCT) for Ophthalmology Market to Reach $754.4 Million by the Year 2026
Optical coherence tomography (OCT), a non-invasive, diagnostic technology is fast becoming an established imaging technology in ophthalmic diagnosis. OCT relies on light waves for capturing high-quality 3D retinal images in a non-invasive manner, enabling medical professionals to study eye conditions.
An aging population, growing prevalence of ocular diseases, rapid increase in diabetic population and increasing focus on curbing healthcare expenditures continue to drive the demand for ophthalmic diagnostic equipment. With rise in the average life span, there is an increasing incidence of ophthalmic and ocular conditions which is a natural phenomenon of aging.
In addition, lifestyle trends and rising levels of pollution in developed and developing countries have put an ever-increasing number of people at risk of developing potential eye allergies, hypersensitivity to environmental elements such as pollen, dust, and dry eye syndrome among others. A key trend in the space is integration of various devices into single equipment. The ongoing shift to spectral domain OCT technology from time domain OCT is spurring growth in the market.
Spectral domain OCT, an advancement in imaging technology enables efficient examination of ocular pathologies. Further infusing growth into the segment is the integration of built in devices such as fundus cameras and OCT scanning laser ophthalmoscopes. Software upgrades in OCT systems are introducing advanced disease-progression analysis featuring greater range in data capture and imaging.
The U.S. Market is Estimated at $169.9 Million in 2021, While China is Forecast to Reach $96.9 Million by 2026
The Optical Coherence Tomography (OCT) for Ophthalmology market in the U.S. is estimated at US$169.9 Million in the year 2021. The country currently accounts for a 30.97% share in the global market.
China, the world`s second largest economy, is forecast to reach an estimated market size of US$96.9 Million in the year 2026 trailing a CAGR of 9.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 6.1% respectively over the analysis period.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/cv36d6
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://healthtechnologynet.com/wp-content/uploads/2022/07/Research_and_Markets_Logo-1.jpg
SOURCE Research and Markets
The new proprietary cell line development platform combines a robust cell line, transposon technology with…
GRASS VALLEY, CA / ACCESSWIRE / June 4, 2024 / Applied Science, the worldwide leader…
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…
SEATTLE, June 4, 2024 /PRNewswire/ -- AffableBPM, a leader in AI-powered business process automation for…
Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services…